4.6 Article

Use of Calcium Channel Blockers and Parkinson's Disease

Related references

Note: Only part of the references are listed.
Article Public, Environmental & Occupational Health

The Danish National Prescription Registry

Helle Wallach Kildemoes et al.

SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)

Article Clinical Neurology

Calcium Channel Blocker Use and Risk of Parkinson's Disease

Kelly Claire Simon et al.

MOVEMENT DISORDERS (2010)

Article Biochemistry & Molecular Biology

PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-induced Cell Death

Sonia Gandhi et al.

MOLECULAR CELL (2009)

Article Medicine, General & Internal

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

C. Warren Olanow et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Review Biochemistry & Molecular Biology

Calcium signaling and neurodegenerative diseases

Ilya Bezprozvanny

TRENDS IN MOLECULAR MEDICINE (2009)

Article Clinical Neurology

Use of antihypertensives and the risk of Parkinson disease

Claudia Becker et al.

NEUROLOGY (2008)

Article Clinical Neurology

Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease

Kelly Claire Simon et al.

NEUROLOGY (2007)

Article Clinical Neurology

Calcium, ageing, and neuronal vulnerability in Parkinson's disease

D. James Surmeier

LANCET NEUROLOGY (2007)

Article Multidisciplinary Sciences

'Rejuvenation' protects neurons in mouse models of Parkinson's disease

C. Savio Chan et al.

NATURE (2007)

Review Cell Biology

Calcium and neurodegeneration

Mark P. Mattson

AGING CELL (2007)

Article Clinical Neurology

Calcium channel blockers and beta-blockers in relation to Parkinson's disease

Thanh G. N. Ton et al.

PARKINSONISM & RELATED DISORDERS (2007)

Review Clinical Neurology

The pathogenesis of cell death in Parkinson's disease

Peter Jenner et al.

NEUROLOGY (2006)

Article Clinical Neurology

Subjective complaints, precede Parkinson disease - The Rotterdam study

LML de Lau et al.

ARCHIVES OF NEUROLOGY (2006)

Article Clinical Neurology

Orthostatic hypotension as an early finding in Parkinson's disease

DS Goldstein

CLINICAL AUTONOMIC RESEARCH (2006)

Review Clinical Neurology

Epidemiology of Parkinson's disease

Lonneke M. L. de Lau et al.

LANCET NEUROLOGY (2006)

Article Health Care Sciences & Services

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

HD Quan et al.

MEDICAL CARE (2005)

Review Medicine, General & Internal

Parkinson's disease

A Samii et al.

LANCET (2004)

Article Multidisciplinary Sciences

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

EM Valente et al.

SCIENCE (2004)

Article Genetics & Heredity

Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease

JM van der Walt et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2003)

Review Clinical Neurology

Dementia associated with Parkinson's disease

M Emre

LANCET NEUROLOGY (2003)

Article Public, Environmental & Occupational Health

Evaluating medication effects outside of clinical trials: New-user designs

WA Ray

AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)

Article Clinical Neurology

A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

MA Hernán et al.

ANNALS OF NEUROLOGY (2002)